A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update. (Q34322740)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update. |
scientific article |
Statements
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update (English)
Cora N Sternberg
Robert E Hawkins
Pamela Salman
Jozef Mardiak
Carlos H Barrios
Juan J Zarba
Oleg A Gladkov
Eunsik Lee
Lauren McCann
Stephen D Rubin
Mei Chen
Ian D Davis
12 January 2013